These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5598901)

  • 41. [Mechanism of action of vitamin K and how it is affected by anticoagulants].
    Schade R; Janowski K
    Pharmazie; 1976; 31(9):585-9. PubMed ID: 798207
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma PIVKA proteins in rabbits given warfarin.
    Zivelin A; Rao LV; Rapaport SI
    Thromb Res; 1996 Jun; 82(5):429-38. PubMed ID: 8771703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of thorium dioxide upon blood clotting and platelets. II. In vivo studies in rabbits.
    McGehee WG; Hjort PF; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):354-70. PubMed ID: 5998918
    [No Abstract]   [Full Text] [Related]  

  • 44. Dietary related plasma vitamin C concentration has no effect on anticoagulation response to warfarin.
    Wynne H; Khan T; Avery P; Wood P; Ward A; Kamali F
    Thromb Res; 2006; 118(4):501-4. PubMed ID: 16139332
    [No Abstract]   [Full Text] [Related]  

  • 45. Experimental warfarin poisoning in the dog. Platelet function, coagulation and fibrinolysis.
    Forbes CD; Thomson C; Prentice CR; McNicol GP; McEwan AD
    J Comp Pathol; 1973 Apr; 83(2):173-80. PubMed ID: 4761660
    [No Abstract]   [Full Text] [Related]  

  • 46. The contribution of plasma (R)- & (S)-warfarin and vitamin K concentrations to intra-individual variability in anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Feb; 83(2):349-50. PubMed ID: 10739399
    [No Abstract]   [Full Text] [Related]  

  • 47. Some effects of purified autoprothrombin C in blood clotting.
    Müller-Berghaus G; Seegers WH
    Thromb Diath Haemorrh; 1966 Dec; 16(3):707-22. PubMed ID: 5996683
    [No Abstract]   [Full Text] [Related]  

  • 48. Hypersensitivity to warfarin in rats with Walker 256 carcinoma.
    Owen CA
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):1-3. PubMed ID: 7063488
    [No Abstract]   [Full Text] [Related]  

  • 49. Vitamin K and warfarin. Metabolism, function and interaction.
    Woolf IL; Babior BM
    Am J Med; 1972 Sep; 53(3):261-7. PubMed ID: 5054720
    [No Abstract]   [Full Text] [Related]  

  • 50. Acquired inhibitors of coagulants.
    Bidwell E
    Annu Rev Med; 1969; 20():63-74. PubMed ID: 4183761
    [No Abstract]   [Full Text] [Related]  

  • 51. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

  • 52. Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.
    Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Middle MV
    Arzneimittelforschung; 1996 Jan; 46(1):41-6. PubMed ID: 8821516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of intravenous administration of T-2 toxin on blood coagulation in calves.
    Gentry PA; Cooper ML
    Am J Vet Res; 1983 May; 44(5):741-6. PubMed ID: 6869975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies.
    Hjort PF; McGehee WG; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663
    [No Abstract]   [Full Text] [Related]  

  • 56. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Warfarin anticoagulation in the horse.
    Scott EA; Byars TD; Lamar AM
    J Am Vet Med Assoc; 1980 Dec; 177(11):1146-51. PubMed ID: 7440316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.
    Pabinger-Fasching I
    Thromb Res; 2008; 122 Suppl 2():S19-22. PubMed ID: 18549908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An assay of the antithrombotic action of warfarin: its correlation with the inhibition of stasis thrombosis in rabbits.
    Wessler S; Gitel SN; Bank H; Martinowitz U; Stephenson RC
    Thromb Haemost; 1979 Feb; 40(3):486-98. PubMed ID: 425063
    [No Abstract]   [Full Text] [Related]  

  • 60. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.